登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Incidence of grade 3 neutropenia during concurrent chemoradiotherapy.
Incidence of grade 3 neutropenia during concurrent chemoradiotherapy.
收藏
Figshare
2025-01-15 更新
2026-04-28 收录
肿瘤治疗毒性
血液学不良反应
数据链接:
https://figshare.com/articles/dataset/Incidence_of_grade_3_neutropenia_during_concurrent_chemoradiotherapy_/28215544
数据链接
链接失效反馈
官方服务:
问题咨询
购买咨询
在线客服
NEW
资源简介:
Incidence of grade 3 neutropenia during concurrent chemoradiotherapy.
应用场景:
创建时间:
2025-01-15
相关数据集
Comparison of grade 3 or 4 toxicities between combined targeted therapy and erlotinib alone.
肿瘤治疗毒性
厄洛替尼副作用
Comparison of grade 3 or 4 toxicities between combined targeted therapy and erlotinib alone.
NIAID Data Ecosystem
7
0
Comparison of grade 3–4 toxicities between EGFR-TKIs and chemotherapy.
肿瘤治疗毒性
EGFR-TKIs副作用
Comparison of grade 3–4 toxicities between EGFR-TKIs and chemotherapy.
NIAID Data Ecosystem
4
0
Acute toxicity according to CTCAE v3.0.
肿瘤治疗毒性
临床试验不良事件
*P-values were calculated with the chi-square test (or Fisher's exact test, if indicated).Acute toxicity according to CTCAE v3.0.
Figshare
2015-12-02 更新
3
0
Baseline values of haematological parameters corresponding to the highest observed CTCAE haematotoxicity grade of any hematologic parameter during PRRT.
肿瘤治疗毒性
血液毒性预测
Baseline values of haematological parameters corresponding to the highest observed CTCAE haematotoxicity grade of any hematologic parameter during PRRT.
NIAID Data Ecosystem
5
0
Toxicities and dose reduction rate of the patients.
肿瘤治疗毒性
临床剂量优化
Toxicities and dose reduction rate of the patients.
Figshare
2017-05-11 更新
3
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广